Zeus is a stylish, simple, non-invasive device to prevent snoring.
Recently cited as one of the leading causes of divorce, chronic snoring affects over one third of the world’s population with an estimated 40% of adult men and 24% of adult women classed as habitual snorers.
It’s not hard to understand this claim and it is backed up by a recent UK study which found that approximately 90% of partners sleeping with a snorer have trouble achieving REM sleep and regularly suffer from sleep deprivation resulting in daytime dysfunction and a host of associated issues.
Aside from the significant psychological and social damage that snoring causes sufferers, this condition has more sinister implications. Multiple studies reveal a positive correlation between loud snoring and risk of heart attack (an increased chance of 34%) and stroke (approximately a 67% higher chance), and habitual snorers are also at greater risk of developing hypertension, type 2 diabetes and high cholesterol.
Obstructive Sleep Apnoea is the world’s most common sleep disorder affecting 100m people worldwide, with 4% of men and 2% of women recorded as sufferers.
A more serious form of snoring, it is a condition where the walls of the throat relax and narrow during sleep, interrupting normal breathing leading to regularly interrupted sleep. It is linked to increased cardiovascular morbidity and mortality, and associated with increased risk of heart attack, cardiac arrhythmia, stroke, daytime sleepiness, depression and poor neurocognitive performance.
Specific risk factors for OSA are weight gain and diabetes, both of which show increasing prevalence in the UK. These figures can be multiplied by a factor of 5-8 for the US market and European markets with an estimated five million OSA patients in western countries who require treatment. The estimated annual economic costs of Obstructive Sleep Apnoea are in the region of £100b.
Evidently there is a desperate need to find some method of preventing snoring which is not only effective but also inexpensive and unobtrusive.
Morgan Innovation & Technology have developed a new device to tackle both snoring and the more severe condition of OSA.
Zeus is small, unobtrusive, reusable and attaches underneath the chin with disposable adhesive stimulation pads. Treatment is carried out by the application of mild electrical stimulation to the pads attached under the chin. Pulses of stimulation contract the muscles in the throat associated with maintaining clear and open airways, but without waking the user.
The technology was successfully trialled for OSA in the Tesla trial between 2013 and 2015 by Dr Joerg Steier at Guy’s & St Thomas’ NHS Foundation Trust and the results of the trial were published in Thorax in July 2017.
Dr. Steier is currently conducting a further clinical trial with the technology in the Tesla-home trial; first trial of domiciliary transcutaneous electrical stimulation, investigating efficacy and compliance in patients with OSA for a three-month period.